Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 03 Nov 2017
ABSCH-IRCC-IN-238768-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/695
Application in Form-III for seeking approval for the invention " Stop Smoking formula Enigma 2x" for obtaining IP Rights in India
26 Jun 2015
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Person:Mr Katragadda Bhaskara RaoD. No. 10-1-30/7, S.D.A. Church Road, Chenchupet, Tenali,Guntur, Andhra Pradesh
522 202, IndiaPhone: +91 8644 230113, +91-9885375156,Fax:Email: katragaddabhaskarrao18@gmail.com,Website:
Person:Mr Babu Vadlamudi1161, Gene Drive,Chelsea, Michigan
48118,Phone:Fax:Email: sandra.vadlamudi@gmail.com,Website:
Confidential information
Yes
1. The user shall notify the NBA within 30 days from the date of grant of IPR.
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes.
3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention “Stop Smoking formula Enigma 2x" in India
Biological Resources:
Thulasi Leaves - Ocimum sanctum
Turmeric - Curcuma longa
Kesar, Kumkum (Saffron) - Crocus sativus
Cardamom Powder - Elettaria cardamomum
Confidential information
- Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee.
2. In case the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument which shall be binding upon such person.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-238768-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
03 Nov 2017 11:07 on 03 Nov 2017 11:07
|
